← FDA Drug Approvals (Drugs@FDA)
BONDLIDO
NDA · New Drug Application · Sponsor: MEDRX USA · Approved 2025-09-24
Drug application
- FDA Application #
NDA215029- Application type
- New Drug Application
- Brand name
- BONDLIDO
- Generic name
- LIDOCAINE
- Active ingredients
- LIDOCAINE
- Dosage form
- SYSTEM
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- MEDRX USA
- Manufacturer
- MEDRx USA, Inc.
- First approval
- 2025-09-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown